Journal
ANGIOGENESIS
Volume 16, Issue 1, Pages 171-179Publisher
SPRINGER
DOI: 10.1007/s10456-012-9310-0
Keywords
F-19 MRI; alpha(v)beta(3) Integrin; PFOB nanoparticle; Glioblastoma; Mouse model
Categories
Funding
- Iseult/Inumac French-German project
Ask authors/readers for more resources
Molecular imaging with magnetic resonance imaging (MRI) targeted contrast agents has emerged as a promising diagnostic approach in cancer research to detect associated biomarkers. In this work, the potential of F-19 MRI was investigated to detect angiogenesis with alpha(nu)beta(3)-targeted perfluorooctylbromide nanoparticles (PFOB NP) in a U87 glioblastoma mouse model at 7 Tesla. Mice were injected intravenously with targeted or non-targeted NP and F-19 images were immediately acquired for 90 min using a PFOB-dedicated MRI sequence. Mice infused with targeted NP exhibited higher concentrations in tumors than mice of the control group, despite the presence of nonspecific signal originating from the blood. Imaging results were corroborated by histology and fluorescence imaging, suggesting specific binding of targeted NP to alpha(nu)beta(3) integrin. Two other groups of mice were injected 24 h before imaging to allow blood clearance but no significant differences were found between both groups, probably due to a loss of specificity of PFOB NP. This is the first demonstration of the ability of F-19 MRI to detect alpha(nu)beta(3)-integrin endothelial expression in brain tumors in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available